1. Home
  2. FOA vs ANIK Comparison

FOA vs ANIK Comparison

Compare FOA & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finance of America Companies Inc.

FOA

Finance of America Companies Inc.

HOLD

Current Price

$22.40

Market Cap

177.1M

Sector

Finance

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$14.92

Market Cap

200.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOA
ANIK
Founded
2013
1983
Country
United States
United States
Employees
784
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.1M
200.9M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
FOA
ANIK
Price
$22.40
$14.92
Analyst Decision
Buy
Buy
Analyst Count
2
1
Target Price
$26.00
$17.00
AVG Volume (30 Days)
66.8K
68.9K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.16
EPS
N/A
N/A
Revenue
N/A
$112,819,000.00
Revenue This Year
$0.58
$5.98
Revenue Next Year
$6.91
$7.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.77
$7.90
52 Week High
$29.79
$16.49

Technical Indicators

Market Signals
Indicator
FOA
ANIK
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
FOA
ANIK

About FOA Finance of America Companies Inc.

Finance of America Companies Inc provides home equity-based financing solutions for modern retirement and offers capital markets and portfolio management capabilities to optimize loan distribution to investors. The Company operates through two segments: Retirement Solutions and Portfolio Management. The Retirement Solutions segment handles loan origination, including HECM and non-agency reverse mortgage loans, generating revenue from origination fees and initial gains, with loans transferred to the Portfolio Management segment. The Portfolio Management segment, which generates the majority of revenue, provides securitization, loan sales, risk management, and asset management services, and earns revenue from net interest income, fair value changes, and servicing-related income.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: